drugset / Trial / NCT01049217

Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy

NCT01049217

Phase 3 Terminated 377 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of pregabalin compared to placebo in reducing neuropathic pain associated with HIV neuropathy.

Timeline

Start
2010-04
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg
Subject Pregabalin Small molecule 300 mg